Literature DB >> 27593175

Calibration and evaluation of routine methods by serum certified reference material for aldosterone measurement in blood.

Tetsuo Nishikawa1, Masao Omura, Migaku Kawaguchi, Akiko Takatsu, Fumitoshi Satoh, Sadayoshi Ito, Isao Kurihara, Hiroshi Itoh, Toshihiko Yanase, Hirotaka Shibata, Yutaka Oki, Mitsuhide Naruse, Keiko Sakurai, Hidehiko Sasamoto, Katsuhiko Kuwa.   

Abstract

We attempted to study the standardization of aldosterone measurement in blood. The serum certified reference material (serum CRM) was established by spiking healthy human serum with pure aldosterone. ID-LC/MS/MS as a reference measurement procedure was performed by using the serum CRM. LC-MS/MS as a comparison method (CM) was routinely used for clinical samples, and the values with and without calibration by the serum CRM were compared. The serum CRM demonstrated similar reactivity with peripheral blood plasma as clinical samples in routine methods (RM) of RIA, ELISA, and CLEIA. In comparison between RM and CM, the results in regression analysis indicated that the range of the correlation coefficient (r) was 0.913 - 0.991, the range of y intercept was 0.9 - 67.3 pg/mL and the range of slope was 0.869 - 1.174. The values by RM in 100 - 150 pg/mL for the diagnostic level, had a significant calibration effect, and the relative difference between calibrated value in RM and result by CM was within ±20%. Furthermore, the calibrated value using the serum CRM was 10,187 pg/mL, which corresponds to measured value of 14,000 pg/mL using RIA for the adrenal venous sampling. Measured values between plasma and serum as a sample for the aldosterone measurement from clinical samples showed no significant differences. In conclusion, we succeeded to prepare the certified reference material of aldosterone for RM. Then, we can accurately calculate corrected values by using our equation for four RMs of determination of aldosterone.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27593175     DOI: 10.1507/endocrj.EJ16-0304

Source DB:  PubMed          Journal:  Endocr J        ISSN: 0918-8959            Impact factor:   2.349


  9 in total

1.  Absolute content determination by quantitative NMR (qNMR) spectroscopy: a curious case of aldosterone.

Authors:  Neeraj Singh; Judith Taibon; Stephan Pongratz; Christian Geletneky
Journal:  RSC Adv       Date:  2021-07-05       Impact factor: 4.036

2.  Clinical Utility of the Adrenocorticotropin Stimulation Test with/without Dexamethasone Suppression for Definitive and Subtype Diagnosis of Primary Aldosteronism.

Authors:  Kosuke Inoue; Masao Omura; Chiho Sugisawa; Yuya Tsurutani; Jun Saito; Tetsuo Nishikawa
Journal:  Int J Mol Sci       Date:  2017-04-30       Impact factor: 5.923

3.  Effects of Repeated Lipopolysaccharide Treatment on Growth Performance, Immune Organ Index, and Blood Parameters of Sprague-Dawley Rats.

Authors:  Youbao Zhong; Xianlai Zhang; Xiaofen Hu; Yong Li
Journal:  J Vet Res       Date:  2018-12-10       Impact factor: 1.744

4.  Re-Assessment of the Oral Salt Loading Test Using a New Chemiluminescent Enzyme Immunoassay Based on a Two-Step Sandwich Method to Measure 24-Hour Urine Aldosterone Excretion.

Authors:  Yoshinori Ozeki; Mizuki Kinoshita; Shotaro Miyamoto; Yuichi Yoshida; Mitsuhiro Okamoto; Koro Gotoh; Takayuki Masaki; Kengo Kambara; Hirotaka Shibata
Journal:  Front Endocrinol (Lausanne)       Date:  2022-03-21       Impact factor: 5.555

5.  Visceral Fat Area Measured by Abdominal Bioelectrical Impedance Analysis in School-Aged Japanese Children.

Authors:  Yuriko Abe; Ryousuke Tonouchi; Mitsuhiko Hara; Tomoo Okada; Eric H Jego; Tetsuya Taniguchi; Tsugumichi Koshinaga; Ichiro Morioka
Journal:  J Clin Med       Date:  2022-07-17       Impact factor: 4.964

6.  Comparison of Echocardiographic Changes Between Surgery and Medication Treatment in Patients With Primary Aldosteronism.

Authors:  Tomomi Ueda; Yuya Tsurutani; Jun Osada; Kosuke Inoue; Yoshitomo Hoshino; Masato Ono; Kazuki Nakai; Jun Saito; Kazuhiko Yumoto; Tetsuo Nishikawa
Journal:  J Am Heart Assoc       Date:  2022-06-29       Impact factor: 6.106

7.  Development of a New Chemiluminescent Enzyme Immunoassay Using a Two-Step Sandwich Method for Measuring Aldosterone Concentrations.

Authors:  Yoshinori Ozeki; Yukie Tanimura; Satoshi Nagai; Takuya Nomura; Mizuki Kinoshita; Kanako Shibuta; Naoki Matsuda; Shotaro Miyamoto; Yuichi Yoshida; Mitsuhiro Okamoto; Koro Gotoh; Takayuki Masaki; Kengo Kambara; Hirotaka Shibata
Journal:  Diagnostics (Basel)       Date:  2021-03-04

Review 8.  Recent Development toward the Next Clinical Practice of Primary Aldosteronism: A Literature Review.

Authors:  Yuta Tezuka; Yuto Yamazaki; Yasuhiro Nakamura; Hironobu Sasano; Fumitoshi Satoh
Journal:  Biomedicines       Date:  2021-03-17

9.  Novel chemiluminescent immunoassay to measure plasma aldosterone and plasma active renin concentrations for the diagnosis of primary aldosteronism.

Authors:  Kyoko Teruyama; Mitsuhide Naruse; Mika Tsuiki; Hiroki Kobayashi
Journal:  J Hum Hypertens       Date:  2021-02-09       Impact factor: 3.012

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.